Amyloid fibril. © Deposition authors: Wasmer, C., Lange, A., Van Melckebeke, H., Siemer, A., Riek, R., Meier, B.H.; visualization author: User:Astrojan - https://www.rcsb.org/structure/2rnm - wikipedia.org

Belgian amyloid fibrils specialist Amyl Therapeutics SA has got a €11n cash injection by existing and new investors and the Walloon region to advance its therapeutic platform.
 

© Dewpoint Therapeutics

German Evotec SE and  Boston-based Dewpoint Therapeutics Inc have entered into a strategic partnership in oncology.

Oncopole Toulouse. © Don-vip - wikipedia.org

Pierre Fabre Laboratories SA has extended its global partnership with Atara Biotherapeutics, licencing tabelecleucel commercialisation rights for Northern America and beyond.

©Quince Creative - pixabay.com

Biotech companies in Scotland’s thriving bio-based manufacturing have been invited to apply for up to £1m funding within the Launchpad programme.

© Memo Therapeutics AG

Swiss Memo Therapeutics AG will use CHF25m raised in a new Series C financing to complete a Phase II study with Anti-BKV for prevention of virus-induced graft damage.
 
   

Christina Lohmeyer und Sasa Ilic (SUNBEAM VISION OHG)

Researchers led by Wolfgang Enard from LMU Munich have identified a microRNA-based mechanism that drives atherosclerosis by weakening the integrity of blood vessel walls.

Cellectis' TALEN technology. © Cellectis SA

AstraZeneca plc has paid French cancer cell therapy developer Cellectis SA US$25m upfront and US$220m in equity in an US$2.2bn R&D deal for up to ten cell and gene therapies.

© NICCOLO BIDDAU/ALFASIGMA

Italian pharma company Alfasigma SpA has signed  a letter of intent to acquire the filgotinib business from Galapagos.

© jarmulok - pixabay.com

Raising $356m through a new Clinical Co-Development Co-Investment Fund (CCD-CIF), Carlyle-subsidiary Abingworth has extended its capital base for late-stage clinical bio-pharma programmes. 

   

© JKian2018 - Pixabay.com

By mapping out associations between human protein networks and herbs used in traditional Chinese medicine (TCM), a Chinese-Bulgarian team can predict relief on various disease symptoms.